Showing results (121-130 of 150) with videos related to
Sort By:
Pageof 15
The European Respiratory Journal|June 28, 2018
Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosisKevin R Flaherty, Charlene D Fell, J Terrill Huggins, et al.The European Respiratory Journal|March 7, 2008
Sex differences in physiological progression of idiopathic pulmonary fibrosisM K Han, S Murray, C D Fell, et al.American Journal of Respiratory and Critical Care Medicine|December 17, 2008
The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosisCharlene D Fell, Lyrica Xiaohong Liu, Caroline Motika, et al.Chest|November 7, 2016
Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity PneumonitisJulie Morisset, Kerri A Johannson, Eric Vittinghoff, et al.American Journal of Respiratory and Critical Care Medicine|January 9, 2010
Clinical predictors of a diagnosis of idiopathic pulmonary fibrosisCharlene D Fell, Fernando J Martinez, Lyrica X Liu, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2010
P2X7 receptor-mediated killing of an intracellular parasite, Toxoplasma gondii, by human and murine macrophagesMichael P Lees, Stephen J Fuller, Rima McLeod, et al.BMC Pulmonary Medicine|November 28, 2019
Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary FibrosisJ H Fisher, M Kolb, M Algamdi, et al.Annals of the American Thoracic Society|May 22, 2020
Costs of Workplace Productivity Loss in Patients with Connective Tissue Disease-associated Interstitial Lung DiseaseMohmmed Algamdi, Mohsen Sadatsafavi, Jolene H Fisher, et al.Chest|May 4, 2019
Costs of Workplace Productivity Loss in Patients With Fibrotic Interstitial Lung DiseaseMohmmed Algamdi, Mohsen Sadatsafavi, Jolene H Fisher, et al.Annals of the American Thoracic Society|January 25, 2021
Treatment Initiation in Patients with Interstitial Lung Disease in CanadaDeborah Assayag, Kristopher Garlick, Kerri A Johannson, et al.Pageof 15